These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24923077)

  • 1. The effect of different doses of subconjunctival bevacizumab on the recurrence rate of excised primary pterygium.
    Razeghinejad R; Banifatemi M; Hosseini H
    Bull Soc Belge Ophtalmol; 2013; (322):13-20. PubMed ID: 24923077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results of subconjunctival bevacizumab in primary pterygium excision.
    Razeghinejad MR; Hosseini H; Ahmadi F; Rahat F; Eghbal H
    Ophthalmic Res; 2010; 43(3):134-8. PubMed ID: 19887878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab and ocular wound healing after primary pterygium excision.
    Banifatemi M; Razeghinejad MR; Hosseini H; Gholampour A
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):17-21. PubMed ID: 20977367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial.
    Shenasi A; Mousavi F; Shoa-Ahari S; Rahimi-Ardabili B; Fouladi RF
    Cornea; 2011 Nov; 30(11):1219-22. PubMed ID: 21955635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up.
    Nava-Castañeda A; Olvera-Morales O; Ramos-Castellon C; Garnica-Hayashi L; Garfias Y
    Clin Exp Ophthalmol; 2014 Apr; 42(3):235-41. PubMed ID: 23777441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: a pilot study.
    Lekhanont K; Patarakittam T; Thongphiew P; Suwan-apichon O; Hanutsaha P
    Cornea; 2012 Feb; 31(2):155-61. PubMed ID: 22081150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical application of bevacizumab as an adjunct to recurrent pterygium surgery.
    Ozgurhan EB; Agca A; Kara N; Yuksel K; Demircan A; Demirok A
    Cornea; 2013 Jun; 32(6):835-8. PubMed ID: 23187164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative subconjunctival bevacizumab as an adjunctive treatment in primary pterygium: a preliminary report.
    Shahin MM; Elbendary AM; Elwan MM
    Ophthalmic Surg Lasers Imaging; 2012; 43(6):459-66. PubMed ID: 22882007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subconjunctival bevacizumab injection in the surgery of primary pterygium: comparison with intraoperative mitomycin-C.
    Kocabora SM; Fazil K; Ozsutcu M; Doyduk-Kocabora A; Gulkilik G
    Bull Soc Belge Ophtalmol; 2013; (322):7-12. PubMed ID: 24923076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients.
    Singh P; Sarkar L; Sethi HS; Gupta VS
    Indian J Ophthalmol; 2015 Oct; 63(10):779-84. PubMed ID: 26655003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated bevacizumab injections versus mitomycin C in rotational conjunctival flap for prevention of pterygium recurrence.
    Ozsutcu M; Ayintap E; Akkan JC; Koytak A; Aras C
    Indian J Ophthalmol; 2014 Apr; 62(4):407-11. PubMed ID: 24178405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of recurrent pterygium with topical bevacizumab 0.05% eye drops: a randomized controlled trial.
    Kasetsuwan N; Reinprayoon U; Satitpitakul V
    Clin Ther; 2015 Oct; 37(10):2347-51. PubMed ID: 26409291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subconjunctival bevacizumab for primary pterygium excision; a randomized clinical trial.
    Razeghinejad MR; Banifatemi M
    J Ophthalmic Vis Res; 2014 Jan; 9(1):22-30. PubMed ID: 24982728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of intralesional bevacizumab administration in primary pterygium: a quantitative analysis.
    Sarac O; Demirel S; Oltulu R
    Eye Contact Lens; 2014 Jan; 40(1):46-50. PubMed ID: 24335454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of subconjunctival bevacizumab for recurrent pterygium.
    Stival LR; Lago AM; Figueiredo MN; Bittar RH; Machado ML; Nassaralla Junior JJ
    Arq Bras Oftalmol; 2014; 77(1):4-7. PubMed ID: 25076364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery.
    Hwang S; Choi S
    Korean J Ophthalmol; 2015 Dec; 29(6):375-81. PubMed ID: 26635453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative mitomycin C versus autologous conjunctival autograft in surgery of primary pterygium with four-year follow-up.
    Koranyi G; Artzén D; Seregard S; Kopp ED
    Acta Ophthalmol; 2012 May; 90(3):266-70. PubMed ID: 20528781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium.
    Bahar I; Kaiserman I; McAllum P; Rootman D; Slomovic A
    Curr Eye Res; 2008 Jan; 33(1):23-8. PubMed ID: 18214740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up.
    Nava-Castañeda A; Ulloa-Orozco I; Garnica-Hayashi L; Hernandez-Orgaz J; Jimenez-Martinez MC; Garfias Y
    J Ocul Pharmacol Ther; 2015 Mar; 31(2):106-13. PubMed ID: 25369364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab in the treatment of pterygium: a meta-analysis.
    Hu Q; Qiao Y; Nie X; Cheng X; Ma Y
    Cornea; 2014 Feb; 33(2):154-60. PubMed ID: 24326333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.